Gabriele Anichini

Siena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Redox-sensitive factors as targets of thiol compounds to hinder SARS-CoV-2 replication and inflammatory response.

Redox-sensitive factors as targets of thiol compounds to hinder SARS-CoV-2 replication and inflammatory response.

Journal: Antimicrobial agents and chemotherapy

Published: July 29, 2026

Molecular evidence of neuroinvasive Sindbis virus infection in humans: detection in cerebrospinal fluid by next generation sequencing.

Molecular evidence of neuroinvasive Sindbis virus infection in humans: detection in cerebrospinal fluid by next generation sequencing.

Journal: Emerging microbes & infections

Published: July 11, 2026

Phenotypic characterization of two neuroinvasive Toscana virus strains clinically associated with self-limited and persistent infections in human neural cells and brain organoids.

Phenotypic characterization of two neuroinvasive Toscana virus strains clinically associated with self-limited and persistent infections in human neural cells and brain organoids.

Journal: Frontiers in cellular and infection microbiology

Published: July 02, 2025

Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity.

Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity.

Journal: Journal of medical virology

Published: August 21, 2024

SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines.

SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines.

Journal: Science immunology

Published: August 09, 2024

Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.

Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.

Journal: Viruses

Published: April 03, 2024

Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.

Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.

Journal: Virology journal

Published: August 01, 2023

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID.

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID.

Journal: Viruses

Published: January 26, 2023

SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.

SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.

Journal: Virus research

Published: January 09, 2023

Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine.

Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine.

Journal: Vaccines

Published: August 19, 2022

Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.

Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.

Journal: Viruses

Published: April 08, 2022

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees.

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees.

Journal: Vaccines

Published: April 06, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026